Genital Diseases, Female  >>  tasisulam (LY573636)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tasisulam (LY573636) / Eli Lilly
NCT00428610 / 2006-005971-17: A Study of Chemotherapy Treatment for Patients With Ovarian Cancer

Completed
2
103
US, Europe, RoW
LY573636-sodium, tasisulam, LY573636
Eli Lilly and Company
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
02/11
01/12

Download Options